Sciclone Pharmaceuticals Inc
SCLN
SCLN was delisted on the 13th of October, 2017.
131 hedge funds and large institutions have $652M invested in Sciclone Pharmaceuticals Inc in 2014 Q4 according to their latest regulatory filings, with 25 funds opening new positions, 47 increasing their positions, 42 reducing their positions, and 8 closing their positions.
213% more first-time investments, than exits
New positions opened: 25 | Existing positions closed: 8
206% more capital invested
Capital invested by funds: $213M → $652M (+$439M)
13% more funds holding
Funds holding: 116 → 131 (+15)
12% more repeat investments, than reductions
Existing positions increased: 47 | Existing positions reduced: 42
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
35% less call options, than puts
Call options by funds: $608K | Put options by funds: $939K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MCM
McKinley Capital Management
Anchorage,
Alaska
|
+$6.86M |
| 2 |
QI
QS Investors
New York
|
+$5.61M |
| 3 |
NI
Numeric Investors
Boston,
Massachusetts
|
+$5.48M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$2.83M |
| 5 |
SFM
Systematic Financial Management
Teaneck,
New Jersey
|
+$2.14M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
LSV Asset Management
Chicago,
Illinois
|
-$4.19M |
| 2 |
NCM
Nantahala Capital Management
New Canaan,
Connecticut
|
-$3.89M |
| 3 |
Franklin Resources
San Mateo,
California
|
-$3.43M |
| 4 |
MC
Menta Capital
San Francisco,
California
|
-$1.92M |
| 5 |
DC
Deere & Company
Moline,
Illinois
|
-$1.41M |
SCLN Hedge Fund Activity: Q4 2014 in Review
131 of the 3,750 institutional investors tracked by Wall St. Rank reported a position in Sciclone Pharmaceuticals Inc (SCLN) for Q4 2014, worth a combined $652M — up 206% from $213M a quarter earlier.
Buyers outnumbered sellers: 25 funds opened new SCLN positions and 8 closed out — a net gain of 17 holders — while 47 added to existing stakes and 42 trimmed.
The largest buyer was McKinley Capital Management, opening a new position worth an estimated $6.86M. The largest seller was LSV Asset Management, cutting an estimated $4.19M.
- 131 institutional investors held Sciclone Pharmaceuticals Inc (SCLN) as of Q4 2014, up from 116 in Q3 2014.
- Funds reported $652M of Sciclone Pharmaceuticals Inc stock for Q4 2014, up 206% quarter-over-quarter.
- 25 funds opened new Sciclone Pharmaceuticals Inc positions in Q4 2014 and 8 closed out, a net change of +17 holders.
- The largest Sciclone Pharmaceuticals Inc buyer in Q4 2014 was McKinley Capital Management, an estimated $6.86M added.
- The largest Sciclone Pharmaceuticals Inc seller in Q4 2014 was LSV Asset Management, an estimated $4.19M sold.
Based on aggregated 13F filings for Q4 2014.